Drug Database
TR
trifluoperazine + trihexyphenidyl (Fluhex forte / Fluhex / Fluhexette)
✓ ApprovedA. N. Pharmacia Laboratories · CHRM1 · Small Molecule
What is trifluoperazine + trihexyphenidyl?
trifluoperazine + trihexyphenidyl is a small molecule developed by A. N. Pharmacia Laboratories. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | Fluhex forte, Fluhex, Fluhexette |
| Company | A. N. Pharmacia Laboratories |
| Drug Class | Small Molecule |
| Molecular Target | CHRM1 |
| Route | Oral (PO) |
| Status | Approved |
Mechanism of Action
Molecular Targets
trifluoperazine + trihexyphenidyl acts on 1 molecular target:
| CHRM1 | cholinergic receptor muscarinic 1 (M1, HM1) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
trifluoperazine + trihexyphenidyl is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Psychiatric disorders | Substance-induced psychotic disorder | ✓ Approved |
Related Research Articles
Unable to load articles right now.